Skip to main content
Xcell Therapeutics Inc. logo

Xcell Therapeutics Inc. — Investor Relations & Filings

Ticker · 373110 ISIN · KR7373110006 KO Manufacturing
Open in API
Filings indexed 86 across all filing types
Latest filing 2025-01-13 Director's Dealing
Country KR South Korea
Listing KO 373110

About Xcell Therapeutics Inc.

https://www.xcell.co.kr/

Xcell Therapeutics Inc. is a company specializing in the research, development, and production of advanced cell culture media. Its primary product line, CellCor™, consists of serum-free, chemically defined media designed to provide an optimal environment for cell culture, particularly for mesenchymal stem cells (MSCs). The technology aims to enhance efficiency and yield for researchers and developers in the fields of cell therapy and regenerative medicine. By offering a serum-free alternative, the company provides a more consistent and defined solution compared to traditional media. Xcell Therapeutics is also expanding its services to become a Contract Development and Manufacturing Organization (CDMO) and is exploring applications for its media in the cultured meat sector.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/Korea Exchange). It details the acquisition of shares by an executive (Joo youn Lee) of Xcell Therapeutics. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders.
2025-01-13 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (the 10th Annual General Meeting). It is not the meeting materials themselves, but a formal notice of the record date for shareholder rights. Given the nature of the announcement regarding corporate governance and meeting preparation, it falls under the general regulatory filing category.
2024-12-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, methods (e.g., open market sales), and updated shareholding percentages. This corresponds to the 'Major Shareholding Notification' category.
2024-11-26 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Xcell Therapeutics' (주식회사 엑셀세라퓨틱스) covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial statements, business descriptions, and management analysis, which is characteristic of an interim/quarterly financial report filed with the Korean financial authorities (Financial Supervisory Service/KRX). 9M 2024
2024-11-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates and volumes. This falls under the category of Major Shareholding Notification (MRQ).
2024-09-03 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Xcell Therapeutics, covering the period from January 1, 2024, to June 30, 2024. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-14 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.